Watanabe, T., Asano, N., Murray, P. J., Ozato, K., Tailor, P., Fuss, I. J., . . . Strober, W. (2008). Muramyl dipeptide activation of nucleotide-binding oligomerization domain 2 protects mice from experimental colitis. American Society for Clinical Investigation.

Watanabe, Tomohiro, Naoki Asano, Peter J. Murray, Keiko Ozato, Prafullakumar Tailor, Ivan J. Fuss, Atsushi Kitani, and Warren Strober. Muramyl Dipeptide Activation of Nucleotide-binding Oligomerization Domain 2 Protects Mice From Experimental Colitis. American Society for Clinical Investigation, 2008.

Watanabe, Tomohiro, et al. Muramyl Dipeptide Activation of Nucleotide-binding Oligomerization Domain 2 Protects Mice From Experimental Colitis. American Society for Clinical Investigation, 2008.